News

C&C Group plc

Spirit rejects C&C acquisition offer, shares plummet

0
Dublin-based C&C Group plc suffered an 11% fall in its share price after the English pub and restaurant firm Spirit Pub Company plc rejected...
TSB

Is TSB too small to be a Challenger Bank?

0
TSB Banking Group plc is too small to be a Challenger Bank, British lawmakers have suggested. The “big five” that dominate UK high street...
Chiquita

Chiquita ditches Fyffes and turns to Brazilian firms

0
Chiquita Brands Inc. has decided to abandon its merger agreement with Dublin-based Fyffes plc and turn to two Brazilian companies, Cutrale and Safra, that...
American Stocks

US stocks had a good week

0
US stocks had a good week, as companies overall posted encouraging quarterly results. Standard & Poor’s had its best week in nearly two years,...
CareerBuilder

Amazing excuses workers use to miss work

0
Would you believe an employee who said he accidentally got onto an airplane, or another who said he or she got stuck in a...
New home sales US

New home sales in September reach six-year high, US

0
New home sales in the United States in September hit a six-year high. According to the US Census Bureau, a total of 467,000 new...
enbridge logo

Enbridge insists its Line 9 pipeline meets all safety standards

0
Enbridge insists that its Line 9 pipeline through southern Ontario is well designed and has the proper shut-off valve configuration, minimizing the risk to reservoirs...
Duracell Spin-Off

Procter & Gamble to spin off Duracell battery business

0
Procter & Gamble is to spin off its Duracell battery business in order to bolster its share price and cut the number of outstanding...
Ford

Ford income falls due to costs of its new F-150 pickup truck

0
Ford’s net income slipped by 34 percent, down to $835 million in the third quarter, with the costs of launching its new pickup truck,...
Shire plc

Shire posts upbeat guidance despite being jilted by AbbVie

0
Dublin based pharmaceutical multinational Shire plc raised its 2014 guidance on Friday, despite being jilted by AbbVie on a $55 billion acquisition deal earlier...